4104 Stock Overview
Sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, the Philippines, and Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 4104 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Excelsior Medical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$85.90 |
| 52 Week High | NT$93.52 |
| 52 Week Low | NT$80.67 |
| Beta | 0.14 |
| 1 Month Change | -1.26% |
| 3 Month Change | -1.94% |
| 1 Year Change | 2.84% |
| 3 Year Change | 73.85% |
| 5 Year Change | 84.49% |
| Change since IPO | 135.24% |
Recent News & Updates
Recent updates
Excelsior Medical's (TWSE:4104) Strong Earnings Are Of Good Quality
Nov 20
There's Been No Shortage Of Growth Recently For Excelsior Medical's (TPE:4104) Returns On Capital
Apr 22A Look At The Intrinsic Value Of Excelsior Medical Co., Ltd. (TPE:4104)
Apr 07What To Know Before Buying Excelsior Medical Co., Ltd. (TPE:4104) For Its Dividend
Feb 25Excelsior Medical (TPE:4104) Could Easily Take On More Debt
Feb 07
Returns On Capital - An Important Metric For Excelsior Medical (TPE:4104)
Jan 22Excelsior Medical (TPE:4104) Has Compensated Shareholders With A Respectable 46% Return On Their Investment
Jan 07Excelsior Medical Co., Ltd. (TPE:4104) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 23Does Excelsior Medical's (TPE:4104) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 08Does Excelsior Medical Co., Ltd. (TPE:4104) Have A Place In Your Dividend Portfolio?
Nov 23Shareholder Returns
| 4104 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | -1.3% | -1.6% | -2.1% |
| 1Y | 2.8% | -10.6% | 25.6% |
Return vs Industry: 4104 exceeded the TW Healthcare industry which returned -10.6% over the past year.
Return vs Market: 4104 underperformed the TW Market which returned 25.6% over the past year.
Price Volatility
| 4104 volatility | |
|---|---|
| 4104 Average Weekly Movement | 0.7% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4104 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4104's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Ming-Cheng Chang | www.excelsiormedical.com.tw |
Excelsior Medical Co., Ltd. sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, the Philippines, and Malaysia. The company offers equipment for hemodialysis/plasma exchange; blood bag; artificial stoma; scar care products; and health appliances. It engages in the investment, real estate, and leasing businesses, as well as selling of precision instrument.
Excelsior Medical Co., Ltd. Fundamentals Summary
| 4104 fundamental statistics | |
|---|---|
| Market cap | NT$14.04b |
| Earnings (TTM) | NT$767.49m |
| Revenue (TTM) | NT$8.45b |
18.3x
P/E Ratio1.7x
P/S RatioIs 4104 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4104 income statement (TTM) | |
|---|---|
| Revenue | NT$8.45b |
| Cost of Revenue | NT$6.73b |
| Gross Profit | NT$1.72b |
| Other Expenses | NT$950.53m |
| Earnings | NT$767.49m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.70 |
| Gross Margin | 20.34% |
| Net Profit Margin | 9.09% |
| Debt/Equity Ratio | 9.8% |
How did 4104 perform over the long term?
See historical performance and comparisonDividends
4.2%
Current Dividend Yield77%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:39 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Excelsior Medical Co., Ltd. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jenny Tsai | BNP Paribas Securities (Asia) |
| Pinghan Hsieh | Capital Securities Corporation |
| Albert Hsu | Daiwa Securities Co. Ltd. |